Mumbai, Nov 9 (UNI) Solara Active Pharma Sciences Ltd, a leading pharmaceutical ingredient provider today announced the completion of United States Food and Drug Administration(USFDA) inspection at its multi-product Active Pharmaceutical Ingredient(API) facility in Mangalore.

As part of GMP compliance audit, the company has received Establishment Inspection Report (EIR) from USFDA, thereby confirming the closure of the inspection in July 2018, company said in a filing with BSE.

Solara's Mangalore facility is one amongst the four USFDA approved facilities in the company. It houses six clean rooms with best in class infrastructure for the development and manufacture of niche APIs and API Intermediates.

UNI JS KAZ SY 1258